Top
image: cbsnews

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

February 7, 2019

Category:

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices. But nearly half of those newly approved drugs aren’t being sold in the United States, Kaiser Health News has found, meaning that many patients are deriving little practical benefit from the administration’s efforts.

Read More on The Medical News